121 related articles for article (PubMed ID: 20950841)
1. Decreased fibrin network permeability and impaired fibrinolysis in the acute and convalescent phase of ischemic stroke.
Rooth E; Wallen NH; Blombäck M; He S
Thromb Res; 2011 Jan; 127(1):51-6. PubMed ID: 20950841
[TBL] [Abstract][Full Text] [Related]
2. Fibrinolytic parameters, lipid status and lipoprotein(a) in ischemic stroke patients.
Vucković BA; Djerić MJ; Ilić TA; Canak VB; Kojić-Damjanov SLj; Zarkov MG; Cabarkapa VS
Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():12-7. PubMed ID: 20229676
[TBL] [Abstract][Full Text] [Related]
3. Increased fibrin formation and impaired fibrinolytic capacity in severe chronic kidney disease.
Mörtberg J; Blombäck M; Wallén Å; He S; Jacobson SH; Spaak J
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):401-7. PubMed ID: 26650459
[TBL] [Abstract][Full Text] [Related]
4. Desirable global assays.
Kluft C
Thromb Res; 2011 Jan; 127(1):4-5. PubMed ID: 21183067
[No Abstract] [Full Text] [Related]
5. Fibrin clot properties in acute ischemic stroke: relation to neurological deficit.
Undas A; Slowik A; Wolkow P; Szczudlik A; Tracz W
Thromb Res; 2010 Apr; 125(4):357-61. PubMed ID: 19942259
[TBL] [Abstract][Full Text] [Related]
6. Altered plasma fibrin clot properties in essential thrombocythemia.
Małecki R; Gacka M; Kuliszkiewicz-Janus M; Jakobsche-Policht U; Kwiatkowski J; Adamiec R; Undas A
Platelets; 2016; 27(2):110-6. PubMed ID: 25989112
[TBL] [Abstract][Full Text] [Related]
7. Thrombin activatable fibrinolysis inhibitor and its relationship to fibrinolysis and inflammation during the acute and convalescent phase of ischemic stroke.
Rooth E; Wallen H; Antovic A; von Arbin M; Kaponides G; Wahlgren N; Blombäck M; Antovic J
Blood Coagul Fibrinolysis; 2007 Jun; 18(4):365-70. PubMed ID: 17473579
[TBL] [Abstract][Full Text] [Related]
8. Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study.
Szczepaniak P; Zabczyk M; Undas A
PLoS One; 2015; 10(4):e0125069. PubMed ID: 25909989
[TBL] [Abstract][Full Text] [Related]
9. Fibrin clot characteristics in acute ischaemic stroke patients treated with thrombolysis: the impact on clinical outcome.
Bembenek JP; Niewada M; Siudut J; Plens K; Członkowska A; Undas A
Thromb Haemost; 2017 Jun; 117(7):1440-1447. PubMed ID: 28382369
[TBL] [Abstract][Full Text] [Related]
10. Altered fibrin clot structure/function in patients with cryptogenic ischemic stroke.
Undas A; Podolec P; Zawilska K; Pieculewicz M; Jedliński I; Stepień E; Konarska-Kuszewska E; Weglarz P; Duszyńska M; Hanschke E; Przewlocki T; Tracz W
Stroke; 2009 Apr; 40(4):1499-501. PubMed ID: 19246700
[TBL] [Abstract][Full Text] [Related]
11. Serial changes in fibrinolysis and coagulation activation markers in acute and convalescent phase of ischemic stroke.
Haapaniemi E; Soinne L; Syrjälä M; Kaste M; Tatlisumak T
Acta Neurol Scand; 2004 Oct; 110(4):242-7. PubMed ID: 15355488
[TBL] [Abstract][Full Text] [Related]
12. A global assay of haemostasis which uses recombinant tissue factor and tissue-type plasminogen activator to measure the rate of fibrin formation and fibrin degradation in plasma.
He S; Zhu K; Skeppholm M; Vedin J; Svensson J; Egberg N; Blombäck M; Wallen H
Thromb Haemost; 2007 Oct; 98(4):871-82. PubMed ID: 17938814
[TBL] [Abstract][Full Text] [Related]
13. Haemostasis in ischaemic stroke and vascular dementia.
Stott DJ; Spilg E; Campbell AM; Rumley A; Mansoor MA; Lowe GD
Blood Coagul Fibrinolysis; 2001 Dec; 12(8):651-7. PubMed ID: 11734665
[TBL] [Abstract][Full Text] [Related]
14. Unfavorably altered fibrin clot properties in patients with active rheumatoid arthritis.
Kwasny-Krochin B; Gluszko P; Undas A
Thromb Res; 2010 Jul; 126(1):e11-6. PubMed ID: 20471669
[TBL] [Abstract][Full Text] [Related]
15. Denser plasma clot formation and impaired fibrinolysis in paroxysmal and persistent atrial fibrillation while on sinus rhythm: association with thrombin generation, endothelial injury and platelet activation.
Drabik L; Wołkow P; Undas A
Thromb Res; 2015 Aug; 136(2):408-14. PubMed ID: 26048399
[TBL] [Abstract][Full Text] [Related]
16. Blood coagulation and fibrinolysis in acute ischaemic and haemorrhagic (intracerebral and subarachnoid haemorrhage) stroke: does decreased plasmin inhibitor indicate increased fibrinolysis in subarachnoid haemorrhage compared to other types of stroke?
Antovic J; Bakic M; Zivkovic M; Ilic A; Blombäck M
Scand J Clin Lab Invest; 2002; 62(3):195-9. PubMed ID: 12088338
[TBL] [Abstract][Full Text] [Related]
17. Effects of acetylsalicylic acid on increase of fibrin network porosity and the consequent upregulation of fibrinolysis.
He S; Bark N; Wang H; Svensson J; Blombäck M
J Cardiovasc Pharmacol; 2009 Jan; 53(1):24-9. PubMed ID: 19129740
[TBL] [Abstract][Full Text] [Related]
18. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
Konieczynska M; Fil K; Bazanek M; Undas A
Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139
[TBL] [Abstract][Full Text] [Related]
19. Plasma fibrin clot properties in atopic dermatitis: links between thrombosis and atopy.
Nastałek M; Wojas-Pelc A; Undas A
J Thromb Thrombolysis; 2010 Aug; 30(2):121-6. PubMed ID: 20419337
[TBL] [Abstract][Full Text] [Related]
20. Acute CO poisoning is associated with impaired fibrinolysis and increased thrombin generation.
Gawlikowski T; Gomolka E; Piekoszewski W; Jawień W; Undas A
Basic Clin Pharmacol Toxicol; 2013 May; 112(5):352-6. PubMed ID: 23228150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
